Explore the preclinical research catching our eye in September 2026, from siRNA and in vivo CRISPR to targeted protein ...

Take a look at the Eli Lilly pipeline in 2026 as the incretin franchise grows and fuels the rest of the company's pipeline.

Discover how early optimization in stable cell line development accelerates timelines and reduces downstream bottlenecks.

Discover Andy Brown's long and arduous journey battling a type of non-Hodgkin lymphoma and how a clinical trial altered his ...

Not a lot went down on the biotech deals front in August 2026, but it did see sustained collaboration in oncology and ...

Chimeric antigen receptors (CARs) are artificial proteins that have been engineered to alter the way immune cells in the body behave – to recognize and destroy harmful cells. These proteins are ...